Researchers have discovered that the protein Hmga1, found in zebrafish, can repair damaged mouse hearts by reactivating ...

KL4 Surfactant is under clinical development by Windtree Therapeutics and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome.

Arsenal have emerged as surprise suitors for struggling Chelsea midfielder Kiernan Dewsbury-Hall, it has been claimed. According to the latest reports, Arsenal are looking to rescue Dewsbury-Hall ...

While terrified pre-surgery, McCallum emerged to cheekily retort: “It shows referees do have a heart.” Asked whether he feared dying, McCallum: “Yes, absolutely. I was almost in shock and ...

Although numerous intravenous agents are available for the treatment of acute decompensated heart failure, there are no current guidelines to help optimize treatment strategies for hospitalized ...

The following are key points to remember from a review on aortic stenosis (AS), heart failure (HF), and aortic valve replacement (AVR): AS is responsible for the development of HF that is mediated ...

Data from multiple Phase 2 studies in patients with early cardiogenic shock or acute decompensated heart failure have demonstrated that istaroxime infused intravenously significantly improves ...

Data from multiple Phase 2 studies in patients with early cardiogenic shock or acute decompensated heart failure have demonstrated that istaroxime infused intravenously significantly improves cardiac ...

A total of 79 patients were enrolled in the study. Five were excluded due to inability to use the VAS; after instruction in use of the VAS, these patients could not adequately perform the task ...

Heart failure with preserved ejection fraction (HFpEF) is a major health concern. Pathological stimuli and interactions between cardiac fibroblasts (CFs) and other cell types may lead to cardiac ...

for use in specific pediatric patients with symptomatic acute decompensated heart failure (ADHF) and cardiogenic shock. A PMA is the highest level of approval granted by the FDA for the safety and ...

allowing their usage in paediatric patients with acute decompensated heart failure (ADHF) and cardiogenic shock. The amendment of PMA specifies the use of the devices for paediatric patients who ...